Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis

  • Claudia E. Weber
  • , Julia Krämer
  • , Matthias Wittayer
  • , Johannes Gregori
  • , Sigurd Randoll
  • , Florian Weiler
  • , Stefan Heldmann
  • , Christina Roßmanith
  • , Michael Platten
  • , Achim Gass*
  • , Philipp Eisele
  • *Korrespondierende/r Autor/-in für diese Arbeit
  • Ruprecht-Karls-Universität Heidelberg
  • Westfälische Wilhelms-Universität Münster
  • Mediri GmbH

Abstract

Objectives
In multiple sclerosis (MS), iron rim lesions (IRLs) are indicators of chronic low-grade inflammation and ongoing tissue destruction. The aim of this study was to assess the relationship of IRLs with clinical measures and magnetic resonance imaging (MRI) markers, in particular brain and cervical cord volume.

Methods
Clinical and MRI parameters from 102 relapsing MS patients (no relapses for at least 6 months, no contrast-enhancing lesions) were included; follow-up data obtained after 12 months was available in 49 patients. IRLs were identified on susceptibility-weighted images (SWIs). In addition to standard brain and spinal cord MRI parameters, normalised cross-sectional area (nCSA) of the upper cervical cord was calculated.

Results
Thirty-eight patients had at least one IRL on SWI MRI. At baseline, patients with IRLs had higher EDSS scores, higher lesion loads (brain and spinal cord), and lower cortical grey matter volumes and a lower nCSA. At follow-up, brain atrophy rates were higher in patients with IRLs. IRLs correlated spatially with T1-hypointense lesions.

Conclusions
Relapsing MS patients with IRLs showed more aggressive MRI disease characteristics in both the cross-sectional and longitudinal analyses.
OriginalspracheEnglisch
ZeitschriftEuropean Radiology
Jahrgang32
Ausgabenummer3
Seiten (von - bis)2012-2022
Seitenumfang11
ISSN0938-7994
DOIs
PublikationsstatusVeröffentlicht - 03.2022

Fördermittel

The authors of this manuscript declare relationships with the following companies: Dr. Krämer has received honoraria for lecturing from Biogen, Novartis, Genzyme, Merck, Mylan, and Teva and financial research support from Sanofi Genzyme and Novartis. Dr. Gregori is managing director of mediri GmbH. Prof. Platten has a consultant relationship with Novartis, Merck, and Genentech/Roche; has received non-personal, institutional honoraria from Medac, Merck, Novartis, TEVA, and Genentech/Roche; and has research agreements with Bayer Health Care. Prof. Gass has received honoraria for lecturing, travel expenses for attending meetings, and financial support for research from Bayer Schering, Biogen Idec, Merck Serono, Novartis, and TEVA Neurosciences. Dr. Eisele has received travel expenses from Bayer Health Care. The remaining authors declare no conflict of interest.

Träger
TEVA Neurosciences
Bayer Schering

    UN SDGs

    Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

    1. SDG 9 – Industrie, Innovation und Infrastruktur
      SDG 9 – Industrie, Innovation und Infrastruktur

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Association of iron rim lesions with brain and cervical cord volume in relapsing multiple sclerosis“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Dieses zitieren